hVIVO is the new name of Retroscreen Virology! (from 15 April 2015).
hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
Thursday, 28 June 2012
Novavax to Review RSV Program at New International Conference on Modern Vaccines - MarketWatch
No comments:
Post a Comment